In the context of GVHD, soluble TNFR1 is increased in the tear fluid of patients compared to that of healthy controls, where it is thought to have a role in reducing inflammation on the eye surface by impairing TNFα-induced intracellular signalling [128]. Here, TNFRSF1A is linked to graft versus host disease.